94 related articles for article (PubMed ID: 21428449)
21. Discovery of inhibitors of MCF-7 tumor cell adhesion to endothelial cells and investigation on their mode of action.
Bild T; Jose J; Hartmann RW
Arch Pharm (Weinheim); 2004 Dec; 337(12):687-94. PubMed ID: 15597402
[TBL] [Abstract][Full Text] [Related]
22. Molecular recognition of CYP26A1 binding pockets and structure-activity relationship studies for design of potent and selective retinoic acid metabolism blocking agents.
Sun B; Song S; Hao CZ; Huang WX; Liu CC; Xie HL; Lin B; Cheng MS; Zhao DM
J Mol Graph Model; 2015 Mar; 56():10-9. PubMed ID: 25541526
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity.
Van Heusden J; Van Ginckel R; Bruwiere H; Moelans P; Janssen B; Floren W; van der Leede BJ; van Dun J; Sanz G; Venet M; Dillen L; Van Hove C; Willemsens G; Janicot M; Wouters W
Br J Cancer; 2002 Feb; 86(4):605-11. PubMed ID: 11870544
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biochemical evaluation of a range of (4-substituted phenyl)sulfonate derivatives of 4-hydroxybenzyl imidazole-based compounds as potent inhibitors of 17alpha-hydroxylase/17,20-lyase (P45017alpha) derived from rat testicular microsomes.
Owen CP; Shahid I; Lee WY; Ahmed S
Bioorg Med Chem Lett; 2010 Sep; 20(17):5345-8. PubMed ID: 20675132
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of LIAZAL, a retinoic acid metabolism blocking agent (RAMBA) with potential clinical applications in oncology and dermatology.
Freyne E; Raeymaekers A; Venet M; Sanz G; Wouters W; De Coster R; Wauwe JV
Bioorg Med Chem Lett; 1998 Feb; 8(3):267-72. PubMed ID: 9871667
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, biochemical evaluation of a range of potent 4-substituted phenyl alkyl imidazole-based inhibitors of the enzyme complex 17alpha-Hydroxylase/17,20-Lyase (P45017alpha).
Shahid I; Patel CH; Dhanani S; Owen CP; Ahmed S
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):18-29. PubMed ID: 18407491
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the ligand binding site of CYP2C8 with CYP26A1 and CYP26B1: a structural basis for the identification of new inhibitors of the retinoic acid hydroxylases.
Foti RS; Diaz P; Douguet D
J Enzyme Inhib Med Chem; 2016; 31(sup2):148-161. PubMed ID: 27424662
[TBL] [Abstract][Full Text] [Related]
28. Potent inhibition of retinoic acid metabolism enzyme(s) by novel azolyl retinoids.
Njar VC; Nnane IP; Brodie AM
Bioorg Med Chem Lett; 2000 Sep; 10(17):1905-8. PubMed ID: 10987414
[TBL] [Abstract][Full Text] [Related]
29. Functional properties and substrate characterization of human CYP26A1, CYP26B1, and CYP26C1 expressed by recombinant baculovirus in insect cells.
Helvig C; Taimi M; Cameron D; Jones G; Petkovich M
J Pharmacol Toxicol Methods; 2011; 64(3):258-63. PubMed ID: 21906690
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics.
Nelson CH; Buttrick BR; Isoherranen N
Curr Top Med Chem; 2013; 13(12):1402-28. PubMed ID: 23688132
[TBL] [Abstract][Full Text] [Related]
31. Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells.
Sonneveld E; van den Brink CE; van der Leede BM; Schulkes RK; Petkovich M; van der Burg B; van der Saag PT
Cell Growth Differ; 1998 Aug; 9(8):629-37. PubMed ID: 9716180
[TBL] [Abstract][Full Text] [Related]
32. Prospective teratology of retinoic acid metabolic blocking agents (RAMBAs) and loss of CYP26 activity.
McCaffery P; Simons C
Curr Pharm Des; 2007; 13(29):3020-37. PubMed ID: 17979744
[TBL] [Abstract][Full Text] [Related]
33. Retinoic acid receptors regulate expression of retinoic acid 4-hydroxylase that specifically inactivates all-trans retinoic acid in human keratinocyte HaCaT cells.
Marikar Y; Wang Z; Duell EA; Petkovich M; Voorhees JJ; Fisher GJ
J Invest Dermatol; 1998 Sep; 111(3):434-9. PubMed ID: 9740237
[TBL] [Abstract][Full Text] [Related]
34. Improved Homology Model of the Human all-trans Retinoic Acid Metabolizing Enzyme CYP26A1.
Awadalla MK; Alshammari TM; Eriksson LA; Saenz-Méndez P
Molecules; 2016 Mar; 21(3):351. PubMed ID: 26999080
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, biological evaluation, and molecular modeling studies of methylene imidazole substituted biaryls as inhibitors of human 17alpha-hydroxylase-17,20-lyase (CYP17)--part II: Core rigidification and influence of substituents at the methylene bridge.
Hu Q; Negri M; Jahn-Hoffmann K; Zhuang Y; Olgen S; Bartels M; Müller-Vieira U; Lauterbach T; Hartmann RW
Bioorg Med Chem; 2008 Aug; 16(16):7715-27. PubMed ID: 18674917
[TBL] [Abstract][Full Text] [Related]
36. Some aryl substituted 2-(4-nitrophenyl)-4-oxo-4-phenylbutanoates and 3-(4-nitrophenyl)-1-phenyl-1,4-butanediols and related compounds as inhibitors of rat liver microsomal retinoic acid metabolising enzymes.
Mason P; Greer VP; Kirby AJ; Simons C; Nicholls PJ; Smith HJ
J Enzyme Inhib Med Chem; 2003 Dec; 18(6):511-28. PubMed ID: 15008516
[TBL] [Abstract][Full Text] [Related]
37. Metabolism of vitamin A and its active metabolite all-trans-retinoic acid in small intestinal enterocytes.
Lampen A; Meyer S; Arnhold T; Nau H
J Pharmacol Exp Ther; 2000 Dec; 295(3):979-85. PubMed ID: 11082432
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of (±)-3-(2-(2-fluorobenzyloxy) naphthalen-6-yl)-2-aminopropanoic acid derivatives as novel PTP1B inhibitors.
Sun LP; Shen Q; Piao HH; Ma WP; Gao LX; Zhang W; Nan FJ; Li J; Piao HR
Eur J Med Chem; 2011 Sep; 46(9):3630-8. PubMed ID: 21680062
[TBL] [Abstract][Full Text] [Related]
39. Retinoic acid-metabolizing enzyme cytochrome P450 26a1 (cyp26a1) is essential for implantation: functional study of its role in early pregnancy.
Han BC; Xia HF; Sun J; Yang Y; Peng JP
J Cell Physiol; 2010 May; 223(2):471-9. PubMed ID: 20112286
[TBL] [Abstract][Full Text] [Related]
40. Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells.
Wouters W; van Dun J; Dillen A; Coene MC; Cools W; De Coster R
Cancer Res; 1992 May; 52(10):2841-6. PubMed ID: 1581897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
